New GDP Rules in Russia - what you need to know
Recommendation

22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
The new GDP rules published in Russia last year have been valid since 1 March 2017. They do of course apply to companies in Russia, but also pharmaceutical companies distributing to Russia should be aware of the new rules on storage and transportation. Companies operating in Russia are now also responsible for ensuring that any contract warehouses and other third party services do meet the same requirements.
So with these new rules which are similar to the EU and PIC/S GDP guidelines, pharmaceutical manufacturers, distributors and warehouses should check their existing quality systems and implement or provide for example:
- Initial and on-going training for all employees involved in GDP
- GDP compliant quality system and standard operating procedures in place
- GDP compliant documentation, record-keeping and reporting
- Separate storage areas for counterfeit medicines
- Appointing a person being responsible for implementing and maintaining the quality system and monitoring its compliance and efficiency
- Monitoring compliance of third party logistic providers and warehouses (including audits)
This Code of Good Practice in the Pharmaceutical Industry is also available in English.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September


